The Office of Technology Licensing was established in 1970 to transfer technologies developed at Stanford. Find out more about OTL's history, mission, staff, and statistics.

Login to TechFinder » 

Skin-Associated Lymphocytes and Markers (HECA-452)


Stanford Reference:

90-088


Abstract


Skin Associated Lymphocytes and Markers (HECA-452)

The invention consists of the ability to diagnose or treat cutaneous chronic inflammatory disorders by the identification, characterization, modulation, or enrichment or depletion of skin-homing or skin-associated lymphocytes defined by expxression of the CLA antigen defined by monoclonal antibody HECA-452. Antibodies to the antigen or other relative agents reactive with CLA may be used for the diagnosis of inglammation and malignancies by employing skin-assoicated lymphocytes or antibodies or cyotoxic agents, which then allows for potential treatment.

Publications


  • American Journal of Pathology, 136:1053-1068, 1990

Innovators & Portfolio



Date Released

 8/30/1997
 

Licensing Contact


Brenda Martino, Biological Materials Specialist
(650) 725-9119 (Direct)
Login to Request Information

[-] Map/Timeline

78-017 Monoclonal Antibodies: 11-6 anti-Ig-5b, 11-5 anti-I-A (2), 11-4 anti-H-2Kk, 11-3 anti-I-A917), 10-4 anti-Ig-5a, H-12 anti-THY 1.2
79-066 Mouse Anti-Human Hybridomas L243, L17F15
82-008 A Monoclonal Antibody Specific For Mouse Granulocytes

more technologies

Related Keywords


research tool   research tool: antibody   research tool: cell line   
 

   

  

Also of Interest...
78-017 Monoclonal Antibodies: 11-6 anti-Ig-5b, 11-5 anti-I-A (2), 11-4 anti-H-2Kk, 11-3 anti-I-A917), 10-4 anti-Ig-5a, H-12 anti-THY 1.2
79-066 Mouse Anti-Human Hybridomas L243, L17F15
82-008 A Monoclonal Antibody Specific For Mouse Granulocytes

Recently Viewed...
S90-088 Skin-Associated Lymphocytes and Markers (HECA-452)